Fetal magnetocardiography (fMCG) registers the magnetic field generate
d by the fetal heart. In contrast to the fetal electrocardiogram, fECG
permits non-invasive registration of fetal heart activity and documen
tation of all parts of the PQRST-wave-forms from the second trimenon o
nwards. This facilitates the determination of cardiac time intervals a
nd establishment of reference values for different stages of pregnancy
. We examined 53 women in 104 recordings from the 10th week of gestati
on onwards (1 to 10 recordings per individual). The fMCG (37 magnetic
channels, sampling rate 1024 Hz, bandwidth 1-200 Hz) was recorded non-
invasively over the mother's abdomen in a magnetically shielded room.
Registration of fetal heart beats was generally successful from the 20
/21th week of gestation onwards. In a few cases, fetal heart beats cou
ld be registered as early as in the 16th week. Cardiac time intervals
and amplitudes of fMCG increased concordantly with fetal growth. Mean
P wave duration increased from 31 to 49 ms (p < 0.05), PQ interval fro
m 95 to 107 ms (n. s.) and QRS duration from 36 to 52 ms (p < 0.01). T
he mean amplitudes of the P and R waves also increased. FMCG, furtherm
ore permits a prenatal diagnosis of fetal cardiac arrhythmias. We reco
rded fetal arrhythmias in 20 cases (26-38th week), including episodes
of ventricular and supraventricular arrhythmias or atrioventricular bl
ockings. Due to its high resolution, fMCG offers new information on th
e development of fetal cardiac activity which cannot be achieved by co
nventional methods like cardiotocography or dopplerultrasound. Therefo
re, fMCG could become a new diagnostic instrument for monitoring fetal
wellbeing during pregnancy.